07.02.2013 Views

jurnalul român de psihofarmacologie romanian journal of ...

jurnalul român de psihofarmacologie romanian journal of ...

jurnalul român de psihofarmacologie romanian journal of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

15. Saria A., 1999 – The tachykinin NK1 receptor in the brain : pharmacology and putative<br />

functions. Eur. J. Pharmacol., 375, 51-60.<br />

16. Ribeiro S.J., Teixeira R.M., Calixto J.B., De Lima T.C., 1999 – Tachykinin NK3 receptor<br />

involvement in anxiety. Neuropepti<strong>de</strong>s, 33, 181-188.<br />

17. 17.Schwartz M.J., Chiang S., Müller N., Ackenhal M., 2001 – T-helper-1 and T-helper-2<br />

reponses in psychiatric disor<strong>de</strong>rs. Brain. Behav. Immun., 15, 340-370.<br />

18. Sni<strong>de</strong>r R.M., Constantine J.W., Lowe J.A. III, et. al., 1991 – A potent nonpepti<strong>de</strong> antagonist<br />

<strong>of</strong> the substance P (NK1) receptor. Science, 251, 435-437.<br />

19. Rupniak N.M.J., Kramer M.S., 1999 – Discovery <strong>of</strong> the anti<strong>de</strong>pressant anti-emetic efficacy<br />

<strong>of</strong> substance P antagonists. Trends Pharmacol. Sci., 20, 485-490.<br />

20. Panocka I., Massi M., Lapo I., Swi<strong>de</strong>rski T., Kowalczyk M., Sadowski B., 2001 –<br />

Anti<strong>de</strong>pressant type effect on the NK3 tachykinin receptor agonist – aminosenkti<strong>de</strong> – in<br />

mouse lines differing in endogenous opioid system activity. Pepti<strong>de</strong>s, 22, 1037-1042.<br />

21. Ribeiro S.J., De Lima T.C., 1998 – Naloxone – induced changes in tachykinin NK3 receptor<br />

modulation <strong>of</strong> experimental anxiety in mice. Neurosc. Lett., 258, 155-158.<br />

22. Humpel S., Saria A., 1993 – Characterisation <strong>of</strong> neurokinin binding sites in rat brain<br />

membranes using highly selective ligands. Neuropepti<strong>de</strong>s, 25, 65-71.<br />

23. Shpeard S.L., Williamson D.J., Williams J. et. al., 1995 – Comparison <strong>of</strong> the effects <strong>of</strong><br />

sumatriptan and the NK1 antagonist CP= 99,994 on plasma extravasation in dura mater and cfos<br />

mRNA expression in trigeminal nucleus caudalis <strong>of</strong> rats. Neuropharmacology, 34, 255-261.<br />

24. Watson J.W., Gonsalves S.F., Fossa A.A. et. al., 1995 – The anti-emetic effects <strong>of</strong> CP-<br />

99,994 in the ferret and the dog: role <strong>of</strong> the NK1 receptor. Br. J. Pharmacol., 115, 84-94.<br />

25. Elliott P.J., Nemer<strong>of</strong>f C.B., Kilts C. D., 1986 – Evi<strong>de</strong>nce for a tonic facilitatory influence <strong>of</strong><br />

substance P on dopamine release in the nucleus accumbens. Brain Res., 385,379-382.<br />

26. Marco N., Thirion A., Mons G. et. al., 1998 – Activation <strong>of</strong> dopaminergic and cholinergic<br />

neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis<br />

approach in guinea pig. Neuropepti<strong>de</strong>s, 32, 481-488.<br />

27. Mantyh P.W., Hunt S.P., Maggio J.E., 1984 – Substance P receptors: localization by light<br />

microscopic autoradiography in rat brain using [H3] SP as the radioligand. Brain Res., 307,<br />

147-165.<br />

28. Kramer M.S., Cutler W., Feighner J. et. al., 1998 – Distinct mechanism for anti<strong>de</strong>pressant<br />

activity by blocka<strong>de</strong> <strong>of</strong> central substance P receptors. Science, 281, 1640-1645.<br />

29. Kramer M.S., Ball W.A., Reines S.A., 2001 – Replication <strong>of</strong> the efficacy and tolerability <strong>of</strong><br />

substance P antagonists in patients with major <strong>de</strong>pression. American College <strong>of</strong> Neuropsychopharmacology<br />

(ACNP) 40-th Anniversary Scientific Abstract Book, Abstract 128.<br />

79

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!